Tuesday January, 23rd 2018

Bitconnect, the lending and exchange platform that was long suspected by many in the crypto community of being a Ponzi scheme, has announced it^s shutting down. In a release on its website the platform said the shutdown is attributed to "continuous bad press" surrounding the platform, two cease and desist letters from both Texas and North Carolina^s securities boards, and continuous DDoS attacks on the platform. While the platform says they^re refunding all outstanding loans at a rate of $363.62 USD (an average of the token^s price over the last 15 days), the Bitconnect token is currently trading down ~80% and worth less than $40, so while users may have been made whole on a BCC-equivlent, many are certainly suffering severe financial losses in terms of USD or Bitcoin (which is how they made their original investment). Many in the cryptocurrency community have openly accused Bitconnnect of running a Ponzi scheme, including Ethereum founder Vitalik Buterin. The platform was powered by a token called BCC (not to be confused with BCH, or Bitcoin Cash), which is essentially useless now that the trading platform has shut down. In the last The token has plummeted more than 80% to about $37, down from over $200 just a few hours ago.
“The CIA also requires eClinicalWorks to allow customers to obtain updated versions of their software free of charge and to give customers the option to have eClinicalWorks transfer their data to another EHR software provider without penalties or service charges,” the notice said. “eClinicalWorks must also retain an Independent Review Organization to review eClinicalWorks arrangements with healthcare providers to ensure compliance with the Anti-Kickback Statute.” At this point it’s hard to pinpoint which will be worse: Customers leaving for rival EHR vendors gobbling up precious market share or being forced to give those medical practices and hospitals that do stick with them free upgrades. And in a market that many analysts say is poised for consolidation, mergers and acquisitions and the usual bloodbath of failed vendors, either of those options is invariably going to hurt.